Philippe Ledru - Apr 13, 2022 Form 4 Insider Report for Aptose Biosciences Inc. (APTO)

Role
Chief Commercial Officer
Signature
/s/ Janet Clennett as attorney-in-fact for Philippe Ledru
Stock symbol
APTO
Transactions as of
Apr 13, 2022
Transactions value $
$0
Form type
4
Date filed
4/14/2022, 08:59 PM
Previous filing
Apr 14, 2022
Next filing
Jan 23, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APTO Employee Stock Option Award $0 +600K $0.00 600K Apr 13, 2022 Common Shares 600K $1.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fifty percent (50%) of the shares vest on 4/13/2023; the remaining 50% vest as follows: 1/3 on 4/13/2024; 1/3 on 4/13/2025; and 1/3 on 4/13/2026.